1513A>C Polymorphism in the P2X7 Receptor Gene in Patients with Papillary Thyroid Cancer: Correlation with Histological Variants and Clinical Parameters
Introduction: The modulation of the purinergic receptor P2X7 may be implicated in human carcinogenesis. The 1513A>C and 489C>T polymorphisms of P2X7R gene induce loss of function and gain of function, respectively. Aim: The aim of the study was to assess the frequency of both 1513A>C and 48...
Saved in:
| Published in | The journal of clinical endocrinology and metabolism Vol. 94; no. 2; pp. 695 - 698 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Bethesda, MD
Oxford University Press
01.02.2009
Endocrine Society |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0021-972X 1945-7197 |
| DOI | 10.1210/jc.2008-1322 |
Cover
| Abstract | Introduction: The modulation of the purinergic receptor P2X7 may be implicated in human carcinogenesis. The 1513A>C and 489C>T polymorphisms of P2X7R gene induce loss of function and gain of function, respectively.
Aim: The aim of the study was to assess the frequency of both 1513A>C and 489C>T polymorphisms in patients with papillary thyroid carcinoma (PTC) and to evaluate the possible association with clinical and histological features.
Patients and Methods: P2X7R analysis was performed in lymphocytes from 121 PTC patients (100 women, 21 men; aged 43.4 ± 13.6 yr), 100 matched healthy subjects, and 80 patients with nodular goiter.
Results: The minor allele frequency for 1513A>C polymorphism in PTC patients with the classical variant was similar to controls (0.21 and 0.20, respectively), whereas it resulted in a significant increase in patients with the follicular variant (0.36; P = 0.01 vs. classical variant, and P = 0.005 vs. controls). In detail, 13.6% of patients with PTC follicular variant were homozygous for the 1513C allele, compared to 2.6% of patients with the classical variant and 2% of controls. Moreover, a positive relationship between 1513A>C polymorphism and either cancer diameter (Rho = 0.22; P = 0.02) or TNM stage (Rho = 0.38; P < 0.001) was found. No significant difference in the genotype frequency of 489C>T polymorphism between PTC patients and healthy controls was observed (0.42 and 0.47, respectively).
Conclusions: Our data show, for the first time, a strong association between 1513A>C polymorphism of P2X7R gene and the follicular variant of PTC. Further studies are needed to confirm the possible role of this polymorphism as a novel clinical marker of PTC follicular variant and its usefulness in selecting patients with different clinical outcome. |
|---|---|
| AbstractList | Introduction: The modulation of the purinergic receptor P2X7 may be implicated in human carcinogenesis. The 1513A>C and 489C>T polymorphisms of P2X7R gene induce loss of function and gain of function, respectively.
Aim: The aim of the study was to assess the frequency of both 1513A>C and 489C>T polymorphisms in patients with papillary thyroid carcinoma (PTC) and to evaluate the possible association with clinical and histological features.
Patients and Methods: P2X7R analysis was performed in lymphocytes from 121 PTC patients (100 women, 21 men; aged 43.4 ± 13.6 yr), 100 matched healthy subjects, and 80 patients with nodular goiter.
Results: The minor allele frequency for 1513A>C polymorphism in PTC patients with the classical variant was similar to controls (0.21 and 0.20, respectively), whereas it resulted in a significant increase in patients with the follicular variant (0.36; P = 0.01 vs. classical variant, and P = 0.005 vs. controls). In detail, 13.6% of patients with PTC follicular variant were homozygous for the 1513C allele, compared to 2.6% of patients with the classical variant and 2% of controls. Moreover, a positive relationship between 1513A>C polymorphism and either cancer diameter (Rho = 0.22; P = 0.02) or TNM stage (Rho = 0.38; P < 0.001) was found. No significant difference in the genotype frequency of 489C>T polymorphism between PTC patients and healthy controls was observed (0.42 and 0.47, respectively).
Conclusions: Our data show, for the first time, a strong association between 1513A>C polymorphism of P2X7R gene and the follicular variant of PTC. Further studies are needed to confirm the possible role of this polymorphism as a novel clinical marker of PTC follicular variant and its usefulness in selecting patients with different clinical outcome. The modulation of the purinergic receptor P2X7 may be implicated in human carcinogenesis. The 1513A>C and 489C>T polymorphisms of P2X7R gene induce loss of function and gain of function, respectively. The aim of the study was to assess the frequency of both 1513A>C and 489C>T polymorphisms in patients with papillary thyroid carcinoma (PTC) and to evaluate the possible association with clinical and histological features. P2X7R analysis was performed in lymphocytes from 121 PTC patients (100 women, 21 men; aged 43.4 +/- 13.6 yr), 100 matched healthy subjects, and 80 patients with nodular goiter. The minor allele frequency for 1513A>C polymorphism in PTC patients with the classical variant was similar to controls (0.21 and 0.20, respectively), whereas it resulted in a significant increase in patients with the follicular variant (0.36; P = 0.01 vs. classical variant, and P = 0.005 vs. controls). In detail, 13.6% of patients with PTC follicular variant were homozygous for the 1513C allele, compared to 2.6% of patients with the classical variant and 2% of controls. Moreover, a positive relationship between 1513A>C polymorphism and either cancer diameter (Rho = 0.22; P = 0.02) or TNM stage (Rho = 0.38; P < 0.001) was found. No significant difference in the genotype frequency of 489C>T polymorphism between PTC patients and healthy controls was observed (0.42 and 0.47, respectively). Our data show, for the first time, a strong association between 1513A>C polymorphism of P2X7R gene and the follicular variant of PTC. Further studies are needed to confirm the possible role of this polymorphism as a novel clinical marker of PTC follicular variant and its usefulness in selecting patients with different clinical outcome. The modulation of the purinergic receptor P2X7 may be implicated in human carcinogenesis. The 1513A>C and 489C>T polymorphisms of P2X7R gene induce loss of function and gain of function, respectively.INTRODUCTIONThe modulation of the purinergic receptor P2X7 may be implicated in human carcinogenesis. The 1513A>C and 489C>T polymorphisms of P2X7R gene induce loss of function and gain of function, respectively.The aim of the study was to assess the frequency of both 1513A>C and 489C>T polymorphisms in patients with papillary thyroid carcinoma (PTC) and to evaluate the possible association with clinical and histological features.AIMThe aim of the study was to assess the frequency of both 1513A>C and 489C>T polymorphisms in patients with papillary thyroid carcinoma (PTC) and to evaluate the possible association with clinical and histological features.P2X7R analysis was performed in lymphocytes from 121 PTC patients (100 women, 21 men; aged 43.4 +/- 13.6 yr), 100 matched healthy subjects, and 80 patients with nodular goiter.PATIENTS AND METHODSP2X7R analysis was performed in lymphocytes from 121 PTC patients (100 women, 21 men; aged 43.4 +/- 13.6 yr), 100 matched healthy subjects, and 80 patients with nodular goiter.The minor allele frequency for 1513A>C polymorphism in PTC patients with the classical variant was similar to controls (0.21 and 0.20, respectively), whereas it resulted in a significant increase in patients with the follicular variant (0.36; P = 0.01 vs. classical variant, and P = 0.005 vs. controls). In detail, 13.6% of patients with PTC follicular variant were homozygous for the 1513C allele, compared to 2.6% of patients with the classical variant and 2% of controls. Moreover, a positive relationship between 1513A>C polymorphism and either cancer diameter (Rho = 0.22; P = 0.02) or TNM stage (Rho = 0.38; P < 0.001) was found. No significant difference in the genotype frequency of 489C>T polymorphism between PTC patients and healthy controls was observed (0.42 and 0.47, respectively).RESULTSThe minor allele frequency for 1513A>C polymorphism in PTC patients with the classical variant was similar to controls (0.21 and 0.20, respectively), whereas it resulted in a significant increase in patients with the follicular variant (0.36; P = 0.01 vs. classical variant, and P = 0.005 vs. controls). In detail, 13.6% of patients with PTC follicular variant were homozygous for the 1513C allele, compared to 2.6% of patients with the classical variant and 2% of controls. Moreover, a positive relationship between 1513A>C polymorphism and either cancer diameter (Rho = 0.22; P = 0.02) or TNM stage (Rho = 0.38; P < 0.001) was found. No significant difference in the genotype frequency of 489C>T polymorphism between PTC patients and healthy controls was observed (0.42 and 0.47, respectively).Our data show, for the first time, a strong association between 1513A>C polymorphism of P2X7R gene and the follicular variant of PTC. Further studies are needed to confirm the possible role of this polymorphism as a novel clinical marker of PTC follicular variant and its usefulness in selecting patients with different clinical outcome.CONCLUSIONSOur data show, for the first time, a strong association between 1513A>C polymorphism of P2X7R gene and the follicular variant of PTC. Further studies are needed to confirm the possible role of this polymorphism as a novel clinical marker of PTC follicular variant and its usefulness in selecting patients with different clinical outcome. Introduction: The modulation of the purinergic receptor P2X7 may be implicated in human carcinogenesis. The 1513A>C and 489C>T polymorphisms of P2X7R gene induce loss of function and gain of function, respectively. Aim: The aim of the study was to assess the frequency of both 1513A>C and 489C>T polymorphisms in patients with papillary thyroid carcinoma (PTC) and to evaluate the possible association with clinical and histological features. Patients and Methods: P2X7R analysis was performed in lymphocytes from 121 PTC patients (100 women, 21 men; aged 43.4 ± 13.6 yr), 100 matched healthy subjects, and 80 patients with nodular goiter. Results: The minor allele frequency for 1513A>C polymorphism in PTC patients with the classical variant was similar to controls (0.21 and 0.20, respectively), whereas it resulted in a significant increase in patients with the follicular variant (0.36; P = 0.01 vs. classical variant, and P = 0.005 vs. controls). In detail, 13.6% of patients with PTC follicular variant were homozygous for the 1513C allele, compared to 2.6% of patients with the classical variant and 2% of controls. Moreover, a positive relationship between 1513A>C polymorphism and either cancer diameter (Rho = 0.22; P = 0.02) or TNM stage (Rho = 0.38; P < 0.001) was found. No significant difference in the genotype frequency of 489C>T polymorphism between PTC patients and healthy controls was observed (0.42 and 0.47, respectively). Conclusions: Our data show, for the first time, a strong association between 1513A>C polymorphism of P2X7R gene and the follicular variant of PTC. Further studies are needed to confirm the possible role of this polymorphism as a novel clinical marker of PTC follicular variant and its usefulness in selecting patients with different clinical outcome. |
| Author | Dardano, Angela Caraccio, Nadia Tognini, Sara Virgilio, Francesco Di Monzani, Fabio Falzoni, Simonetta Polini, Antonio Solini, Anna Berti, Piero |
| Author_xml | – sequence: 1 givenname: Angela surname: Dardano fullname: Dardano, Angela organization: 1Departments of Internal Medicine (A.D., N.C., A.P., S.T., A.S., F.M.), University of Pisa, 56126 Pisa, Italy – sequence: 2 givenname: Simonetta surname: Falzoni fullname: Falzoni, Simonetta organization: 3Department of Experimental and Diagnostic Medicine (S.F., F.D.V.), University of Ferrara, 44100 Ferrara, Italy – sequence: 3 givenname: Nadia surname: Caraccio fullname: Caraccio, Nadia organization: 1Departments of Internal Medicine (A.D., N.C., A.P., S.T., A.S., F.M.), University of Pisa, 56126 Pisa, Italy – sequence: 4 givenname: Antonio surname: Polini fullname: Polini, Antonio organization: 1Departments of Internal Medicine (A.D., N.C., A.P., S.T., A.S., F.M.), University of Pisa, 56126 Pisa, Italy – sequence: 5 givenname: Sara surname: Tognini fullname: Tognini, Sara organization: 1Departments of Internal Medicine (A.D., N.C., A.P., S.T., A.S., F.M.), University of Pisa, 56126 Pisa, Italy – sequence: 6 givenname: Anna surname: Solini fullname: Solini, Anna organization: 1Departments of Internal Medicine (A.D., N.C., A.P., S.T., A.S., F.M.), University of Pisa, 56126 Pisa, Italy – sequence: 7 givenname: Piero surname: Berti fullname: Berti, Piero organization: 2Surgery (P.B.), University of Pisa, 56126 Pisa, Italy – sequence: 8 givenname: Francesco Di surname: Virgilio fullname: Virgilio, Francesco Di organization: 3Department of Experimental and Diagnostic Medicine (S.F., F.D.V.), University of Ferrara, 44100 Ferrara, Italy – sequence: 9 givenname: Fabio surname: Monzani fullname: Monzani, Fabio email: fmonzani@med.unipi.it organization: 1Departments of Internal Medicine (A.D., N.C., A.P., S.T., A.S., F.M.), University of Pisa, 56126 Pisa, Italy |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21145486$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19017759$$D View this record in MEDLINE/PubMed |
| BookMark | eNp10k9vFCEUAHBiauy2evNsSIx6cSqPYYbBg0kz0dakiRtTTW-EYRiXzQyMwMbsN_Hjyv6xh0ZPBPg94L3HGTpx3hmEngO5AArk3VpfUEKaAkpKH6EFCFYVHAQ_QQtCKBSC07tTdBbjmhBgrCqfoFMQBDivxAL9hgrKyw8tXvpxO_kwr2ycsHU4rQxe0juOvxpt5uQDvjLO7HaWKlnjUsS_bFrl2WzHUYUtvl1tg7c9bpXTJrzHrQ_BjBl7d6DXNiY_-h9WqxF_V8Gq3SnK5ZDRuv3qUgU1mWRCfIoeD2qM5tlxPEffPn28ba-Lmy9Xn9vLm0JTwVLRdY1ibOigUUD6ThjeDaVQYISpCKtIWVcKNOm1aigRmiqtlBm4IryvAIamPEevD-fOwf_cmJjkZKM2OSVn_CbKum4aLhjP8OUDuPab4PLbZAk1Y5SJErJ6cVSbbjK9nIOdcnHk34pn8OoIVMwZDyFXy8Z7RwFYxZo6O3pwOvgYgxmktmlfzBSUHSUQuWu_XGu5a7_ctT8HvX0QdH__v_mbA_eb-X9y_6_KPwUevIA |
| CODEN | JCEMAZ |
| CitedBy_id | crossref_primary_10_4132_KoreanJPathol_2014_48_1_30 crossref_primary_10_1007_s11302_013_9372_5 crossref_primary_10_1016_j_jpsychires_2009_10_005 crossref_primary_10_3342_ceo_2011_4_3_149 crossref_primary_10_1016_j_cellimm_2012_05_005 crossref_primary_10_1186_1477_5751_13_16 crossref_primary_10_1038_s41467_017_00887_9 crossref_primary_10_3390_cells10010189 crossref_primary_10_1007_s00109_021_02041_x crossref_primary_10_3342_ceo_2014_7_1_42 crossref_primary_10_1097_CCO_0b013e328334b4d9 crossref_primary_10_3389_fimmu_2015_00402 crossref_primary_10_1016_j_autneu_2015_04_010 crossref_primary_10_1007_s43032_022_01022_w crossref_primary_10_12659_MSM_895763 crossref_primary_10_1007_s12020_010_9384_7 crossref_primary_10_3390_ijms25052495 crossref_primary_10_1016_j_bioorg_2023_106796 crossref_primary_10_1016_j_cellsig_2024_111281 crossref_primary_10_1074_jbc_M109_053082 crossref_primary_10_3389_fphar_2020_00793 crossref_primary_10_1042_BSR20193877 crossref_primary_10_18632_oncotarget_4926 crossref_primary_10_1007_s11302_022_09858_2 crossref_primary_10_15252_embj_2021108130 crossref_primary_10_1097_CCO_0b013e328333846f crossref_primary_10_3389_fnmol_2020_00008 crossref_primary_10_1007_s12026_011_8203_4 crossref_primary_10_1007_s11302_021_09811_9 crossref_primary_10_1242_jcs_099374 crossref_primary_10_1080_2162402X_2022_2059878 crossref_primary_10_1016_j_bbamem_2014_10_029 crossref_primary_10_1016_j_prp_2011_12_009 crossref_primary_10_1089_gtmb_2014_0271 crossref_primary_10_3390_ijms25126673 crossref_primary_10_1007_s00432_020_03379_4 crossref_primary_10_1186_s12935_024_03339_9 crossref_primary_10_5005_jp_journals_10002_1035 crossref_primary_10_1016_j_bj_2016_08_006 crossref_primary_10_1007_s11302_020_09737_8 |
| Cites_doi | 10.1016/j.tips.2006.02.004 10.1023/B:BREA.0000010670.85915.0f 10.1677/ERC-07-0085 10.4049/jimmunol.176.4.2152 10.1210/jc.2003-031425 10.4049/jimmunol.176.7.3877 10.1016/0167-5699(95)80045-X 10.1016/S0031-6997(24)01373-5 10.1111/j.0309-0167.2004.01798.x 10.1016/S0014-5793(99)00270-7 10.4049/jimmunol.175.1.82 10.1210/en.2004-1527 10.1210/en.2007-1223 10.1074/jbc.M010353200 10.1016/S0140-6736(02)08156-4 10.1091/mbc.e04-11-1025 10.1002/jcp.20704 10.1016/j.jamcollsurg.2006.12.037 10.1046/j.1523-1747.2003.12379.x |
| ContentType | Journal Article |
| Copyright | Copyright © 2009 by The Endocrine Society 2009 2009 INIST-CNRS Copyright © 2009 by The Endocrine Society |
| Copyright_xml | – notice: Copyright © 2009 by The Endocrine Society 2009 – notice: 2009 INIST-CNRS – notice: Copyright © 2009 by The Endocrine Society |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM H94 K9. 7X8 |
| DOI | 10.1210/jc.2008-1322 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1945-7197 |
| EndPage | 698 |
| ExternalDocumentID | 19017759 21145486 10_1210_jc_2008_1322 10.1210/jc.2008-1322 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Report |
| GrantInformation_xml | – fundername: Telethon grantid: GGP06070 |
| GroupedDBID | --- -~X .55 .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 4.4 48X 53G 5GY 5RS 5YH 8F7 AABZA AACZT AAIMJ AAPQZ AAPXW AARHZ AAUAY AAVAP AAWTL ABBLC ABDFA ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABVGC ABWST ABXVV ACGFO ACGFS ACPRK ACUTJ ACYHN ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK AELWJ AEMDU AENEX AENZO AERZD AETBJ AEWNT AFCHL AFFNX AFFZL AFGWE AFOFC AFRAH AFXAL AGINJ AGKRT AGQXC AGUTN AHMBA AHMMS AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT ARIXL ASPBG ATGXG AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BSWAC BTRTY C45 CDBKE CS3 D-I DAKXR DIK E3Z EBS EJD EMOBN ENERS F5P FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 HZ~ H~9 KBUDW KOP KQ8 KSI KSN L7B M5~ MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NVLIB O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G REU ROX ROZ TEORI TJX TLC TR2 TWZ VVN W8F WOQ X7M YBU YFH YHG YOC YSK ZY1 ~02 ~H1 AAYXX ABXZS ADNBA AEMQT AEOTA AFYAG AGORE ALXQX CITATION NU- .GJ 08R 3O- 3V. AABJS AABMN AAJQQ AAKAS AAPGJ AAQQT AAUQX AAWDT AAYJJ ABFLS ABSAR ACFRR ACIMA ADEIU ADGIM ADMTO ADZCM AELNO AFXEN AGVJH AI. AIKOY AIMBJ AQDSO AQKUS ASMCH AYOIW AZQFJ BBAFP BENPR BGYMP BHONS BPHCQ BVXVI BYORX DPPUQ EIHJH FEDTE G8K HVGLF IAO IHR INH IQODW J5H MBLQV N95 PQEST PQQKQ PQUKI PROAC TCN TMA VH1 WHG X52 ZA5 ZGI ZXP 7X7 88E 8FI 8FJ ABDPE ABUWG ACVCV ACZBC AFFQV AFKRA AGMDO AHGBF AJBYB AJDVS APJGH AVNTJ CCPQU CGR CUY CVF ECM EIF FYUFA HMCUK ITC M1P NPM OBFPC PHGZM PHGZT PMFND PSQYO UKHRP 7QP 7T5 7TM H94 K9. 7X8 |
| ID | FETCH-LOGICAL-c294t-bb8a44fb18a10db9e7bf39a1e9e50450365a1c0dca8209c2acaaef7a07d511f83 |
| ISSN | 0021-972X |
| IngestDate | Fri Sep 05 10:13:45 EDT 2025 Mon Jun 30 12:43:39 EDT 2025 Fri May 30 10:59:43 EDT 2025 Fri Nov 25 13:53:45 EST 2022 Tue Jul 01 04:01:30 EDT 2025 Thu Apr 24 22:51:10 EDT 2025 Fri Feb 07 10:35:31 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Endocrinopathy Human Obesity Correlation Papillary carcinoma Genetic variability Nutrition Thyroid diseases Nutrition disorder Genotype Patient Metabolic diseases Histology Malignant tumor P2X7 purinergic receptor Variant Thyroid cancer Gene Genetics Endocrinology Nutritional status Cancer Polymorphism |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c294t-bb8a44fb18a10db9e7bf39a1e9e50450365a1c0dca8209c2acaaef7a07d511f83 |
| Notes | SourceType-Scholarly Journals-1 content type line 14 ObjectType-Report-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| PMID | 19017759 |
| PQID | 3164424931 |
| PQPubID | 2046206 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_66887947 proquest_journals_3164424931 pubmed_primary_19017759 pascalfrancis_primary_21145486 crossref_citationtrail_10_1210_jc_2008_1322 crossref_primary_10_1210_jc_2008_1322 oup_primary_10_1210_jc_2008-1322 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2009-Feb |
| PublicationDateYYYYMMDD | 2009-02-01 |
| PublicationDate_xml | – month: 02 year: 2009 text: 2009-Feb |
| PublicationDecade | 2000 |
| PublicationPlace | Bethesda, MD |
| PublicationPlace_xml | – name: Bethesda, MD – name: United States – name: Washington |
| PublicationTitle | The journal of clinical endocrinology and metabolism |
| PublicationTitleAlternate | J Clin Endocrinol Metab |
| PublicationYear | 2009 |
| Publisher | Oxford University Press Endocrine Society |
| Publisher_xml | – name: Oxford University Press – name: Endocrine Society |
| References | Cabrini (2020071613113732400_R8) 2005; 175 Pines (2020071613113732400_R16) 2006; 209 Slater (2020071613113732400_R4) 2004; 83 Gu (2020071613113732400_R9) 2001; 276 (2020071613113732400_R11) 2002 White (2020071613113732400_R17) 2006; 27 Greig (2020071613113732400_R5) 2003; 121 Slater (2020071613113732400_R3) 2004; 44 Puxeddu (2020071613113732400_R12) 2004; 89 Ralevic (2020071613113732400_R1) 1998; 50 Ferrari (2020071613113732400_R2) 2006; 176 Wiley (2020071613113732400_R10) 2002; 359 Ferrari (2020071613113732400_R13) 1999; 447 Larson (2020071613113732400_R20) 2007; 204 Caraccio (2020071613113732400_R6) 2005; 146 Riesco-Eizaguirre (2020071613113732400_R15) 2007; 14 Kawamura (2020071613113732400_R19) 2006; 176 Di Virgilio (2020071613113732400_R18) 1995; 16 Solini (2020071613113732400_R7) 2008; 149 Adinolfi (2020071613113732400_R14) 2005; 16 |
| References_xml | – volume: 27 start-page: 211 year: 2006 ident: 2020071613113732400_R17 article-title: P2 receptors and cancer. publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2006.02.004 – volume: 83 start-page: 1 year: 2004 ident: 2020071613113732400_R4 article-title: Differentiation between cancerous and normal hyperplastic lobules in breast lesions. publication-title: Breast Cancer Res Treat doi: 10.1023/B:BREA.0000010670.85915.0f – volume: 14 start-page: 957 year: 2007 ident: 2020071613113732400_R15 article-title: New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy. publication-title: Endocr Relat Cancer doi: 10.1677/ERC-07-0085 – volume: 176 start-page: 2152 year: 2006 ident: 2020071613113732400_R19 article-title: P2X7 receptors regulate NKT cells in autoimmune hepatitis. publication-title: J Immunol doi: 10.4049/jimmunol.176.4.2152 – volume: 89 start-page: 2414 year: 2004 ident: 2020071613113732400_R12 article-title: BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031425 – start-page: 77 year: 2002 ident: 2020071613113732400_R11 article-title: AJCC cancer staging manual publication-title: In: Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, eds. 6th ed. New York, Berlin, Heidelberg: Springer-Verlag; – volume: 176 start-page: 3877 year: 2006 ident: 2020071613113732400_R2 article-title: The P2X7 receptor: a key player in IL-1 processing and release. publication-title: J Immunol doi: 10.4049/jimmunol.176.7.3877 – volume: 16 start-page: 524 year: 1995 ident: 2020071613113732400_R18 article-title: The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. publication-title: Immunol Today doi: 10.1016/0167-5699(95)80045-X – volume: 50 start-page: 413 year: 1998 ident: 2020071613113732400_R1 article-title: Receptors for purines and pyrimidines. publication-title: Pharmacol Rev doi: 10.1016/S0031-6997(24)01373-5 – volume: 44 start-page: 206 year: 2004 ident: 2020071613113732400_R3 article-title: Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors. publication-title: Histopathology doi: 10.1111/j.0309-0167.2004.01798.x – volume: 447 start-page: 71 year: 1999 ident: 2020071613113732400_R13 article-title: P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. publication-title: FEBS Lett doi: 10.1016/S0014-5793(99)00270-7 – volume: 175 start-page: 82 year: 2005 ident: 2020071613113732400_R8 article-title: A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. publication-title: J Immunol doi: 10.4049/jimmunol.175.1.82 – volume: 146 start-page: 3172 year: 2005 ident: 2020071613113732400_R6 article-title: Extracellular adenosine 5′-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. publication-title: Endocrinology doi: 10.1210/en.2004-1527 – volume: 149 start-page: 389 year: 2008 ident: 2020071613113732400_R7 article-title: Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? publication-title: Endocrinology doi: 10.1210/en.2007-1223 – volume: 276 start-page: 11135 year: 2001 ident: 2020071613113732400_R9 article-title: A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. publication-title: J Biol Chem doi: 10.1074/jbc.M010353200 – volume: 359 start-page: 1114 year: 2002 ident: 2020071613113732400_R10 article-title: A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. publication-title: Lancet doi: 10.1016/S0140-6736(02)08156-4 – volume: 16 start-page: 3260 year: 2005 ident: 2020071613113732400_R14 article-title: Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. publication-title: Mol Biol Cell doi: 10.1091/mbc.e04-11-1025 – volume: 209 start-page: 44 year: 2006 ident: 2020071613113732400_R16 article-title: Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway. publication-title: J Cell Physiol doi: 10.1002/jcp.20704 – volume: 204 start-page: 764 year: 2007 ident: 2020071613113732400_R20 article-title: Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2006.12.037 – volume: 121 start-page: 315 year: 2003 ident: 2020071613113732400_R5 article-title: Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. publication-title: J Invest Dermatol doi: 10.1046/j.1523-1747.2003.12379.x |
| SSID | ssj0014453 |
| Score | 2.1194923 |
| Snippet | Introduction: The modulation of the purinergic receptor P2X7 may be implicated in human carcinogenesis. The 1513A>C and 489C>T polymorphisms of P2X7R gene... The modulation of the purinergic receptor P2X7 may be implicated in human carcinogenesis. The 1513A>C and 489C>T polymorphisms of P2X7R gene induce loss of... |
| SourceID | proquest pubmed pascalfrancis crossref oup |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 695 |
| SubjectTerms | Adult Alleles Biological and medical sciences Biomarkers, Tumor - genetics Biomarkers, Tumor - physiology Carcinogenesis Carcinoma, Papillary - genetics Carcinoma, Papillary - pathology Carcinoma, Papillary, Follicular - genetics Case-Control Studies DNA Mutational Analysis Endocrinopathies Feeding. Feeding behavior Female Fundamental and applied biological sciences. Psychology Gene Frequency Gene polymorphism Genetic Predisposition to Disease Goiter Goiter, Nodular - genetics Goiter, Nodular - pathology Humans Lymphocytes Male Malignant tumors Medical sciences Middle Aged Papillary thyroid cancer Papillary thyroid carcinoma Polymorphism Polymorphism, Single Nucleotide Receptors, Purinergic P2 - genetics Receptors, Purinergic P2X7 Thyroid cancer Thyroid Neoplasms - genetics Thyroid Neoplasms - pathology Thyroid. Thyroid axis (diseases) Tumor Burden - genetics Vertebrates: anatomy and physiology, studies on body, several organs or systems Vertebrates: endocrinology |
| Title | 1513A>C Polymorphism in the P2X7 Receptor Gene in Patients with Papillary Thyroid Cancer: Correlation with Histological Variants and Clinical Parameters |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/19017759 https://www.proquest.com/docview/3164424931 https://www.proquest.com/docview/66887947 |
| Volume | 94 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fi9NAEF7qCSKI-Nvqee6D91QiTbLJdn0QSmk95O4s2Erfwmaz4SolLW36cPeX-Cf6ZziT3U1TvIr6Ekp2s4TMl5350m9mCHkHTp2HMfPBAlHqsR5wVunnwtMqF6hSyGVVYuPiMj6bss-zaNZq_WyolrZl-l7d3JpX8j9WhXNgV8yS_QfL1ovCCfgN9oUjWBiOf2Vj8KNh_zQcDlDGBiQenhn2vLDSxXEw4xgW6hXw6qq-NI6MTSFVm9U2litsO7S-7kyurtfLedYZIAyq3pEDbNxhpHJmclVSxO2V34BkVxoa_PI-cPmVY4lir9LK6l3Ui1hslKioszF1kS1h1yp2daDgWkDlwtU1NJ_QM1mYZBwU4NZuZCQXN8uqIVXnKwCu0GW5Ux1hFWo1Xxr_kc3rAZT7mWv62DzZiNDqrx7CCaUdR749m7K506P0hFet2sHPmc1dsMjjvtEDu93ftFi2KA8aW3lsmn_aqCA2vbJ_czjAmNHhVMUwgY6HJsl6v6735ZdkND0_TybD2eQOuRtwXgkKPs1qMRKwWlsv1d61TdHA_Krm2nvBk0nIfLCSG7BYbtqwHOZJVbw0eUQeWqJD-wa1j0lLF0_IvQsr5XhKflTg_TigTejSeUEBuhShSx10KUIXRxx0KaKR1tClFrrUQPcDbQDXTG0ClzrgUsAbdcClO-A-I9PRcDI482ybEE8FgpVemvYkY3nq96TfzVKheZqHQvpa6AgIC4RokfRVN1MSol2hAqmk1DmXXZ4B28h74XNyVABKXxLaTSOVhXkMy2imRCq7qco141zlvTxMozbpuOefKFtDH1u5LBLk0mCt5LsyjV3RWm1yWs9emdoxB-ZRMOWhKZ6ZcrJn53py4PssYr24TY6d4RP7Qm-S0Ae2EzAR-m3yth4G_4F_CspCL7ebJI4hzBCMt8kLA5fdfQBV4DwSr_689Gtyf_eCHpOjcr3VbyBQL9OTCuO_ALwP7nI |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1513A%3EC+Polymorphism+in+the+P2X7+Receptor+Gene+in+Patients+with+Papillary+Thyroid+Cancer%3A+Correlation+with+Histological+Variants+and+Clinical+Parameters&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Dardano%2C+Angela&rft.au=Falzoni%2C+Simonetta&rft.au=Caraccio%2C+Nadia&rft.au=Polini%2C+Antonio&rft.date=2009-02-01&rft.pub=Oxford+University+Press&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=94&rft.issue=2&rft.spage=695&rft.epage=698&rft_id=info:doi/10.1210%2Fjc.2008-1322&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |